As is true in most industries, adoption of AI and machine learning (ML) is real and accelerating across the biopharma industry. However, most use cases center around applicatio ...

An iPSC manufacturing strategy for cell therapies drops the cost of goods sold to about $5,000 per dose, down from $115,000 per dose for autologous therapeutics and $40,000 per dose for allogeneic ...

PerturbFate can systematically map how diverse disease-associated genetic variations reshape cells to understand complex diseases, like cancer.

End-to-end digital twins for continuous automated manufacturing could slash production costs compared to batch manufacturing.

Filtration study shows strong leachable clearance and predictive modeling for safer biologics manufacturing processes.

Researchers say knowing that semaglutide improves liver health independently of weight loss could influence prescribing decisions.

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

The dosing of these two patients demonstrates Cellares’ GMP manufacturing and supply chain capabilities with their automated platform.

AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery.

The honorees are scheduled to deliver lectures during this year’s meeting in San Diego, CA, which runs from April 17-22.

Regeneron Pharmaceuticals plans to expand its pipeline into radiopharmaceutical therapies through an up to $4.3 billion collaboration with Telix Pharmaceuticals to co-develop and co-commercialize ...

The scientists driving Neion Bio’s effort to engineer chickens as scalable, lower-cost platforms for biologics manufacturing.